Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REAPPRAISED: Riociguat in Triple Therapy for Pulmonary Arterial Hypertension - A Single-Center Retrospective Study With Composite Endpoint Evaluation

NCT07374302 is registered in ClinicalTrials.gov with Caio Júlio César dos Santos Fernandes as lead sponsor.

NCT NCT07374302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07374302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REAPPRAISED: Riociguat in Triple Therapy for Pulmonary Arterial Hypertension - A Single-Center Retrospective Study With Composite Endpoint Evaluation
Lead sponsor
Caio Júlio César dos Santos Fernandes
Phase
Observational
Overall status
Not yet recruiting
Start date
March 1, 2026
Completion date
December 31, 2026
Enrollment
15 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary arterial hypertension